No rads after grade 3 lumpectomy

Options
Tadykins
Tadykins Member Posts: 12

Hi.. I have had a lumpectomy for grade 3 dcis. It was small only 6mm and the margins were clear. my radiologist recommended no rads as she felt that dcis is being over treated. I went along with her recommendation. I am now feeling nervous about my decision. its too late now to change my mind as I had my lumpectomy at the end of march last. Most of the information that I have looked up about dcis....have said that rads is recommended after lumpectomy especially if it's a grade 3.. as this grade is more active.. has anyone else here with grade 3 not had rads? I am not due my next mamo until Feb 2017 and that seems a long way away now as I am feeling nervous that the wrong decision may have been made.. does anyone have any words of wisdom for me? help...

Comments

  • momzr
    momzr Member Posts: 111
    edited October 2016

    Tadykins - while my situation is not identical to yours, I also had and tiny area (1.6 mm) of DCIS removed eight years ago and did NOT choose to follow it with radiation. Here is my DCIS 'story' - I had my diagnosis of DCIS back in July, 2008 -- left breast -- after a digital mamm which showed a cluster of microcalcifications followed by a lumpectomy/surgical excision. As mentioned above, mine was a very small focus area of DCIS (1.6 mm) with nothing identified as comedo (path report indicated solid & cribriform) NO necrosis present, considered intermediate grade, and I had clear margins after the surgical excision/lumpectomy. I have not had any additional treatment besides my excisional biopsy/surgical excision in July '08 which got that tiny area of DCIS out. At follow up appt. a week after that biopsy, a medical oncologist spoke with me and told me that my tumor was so tiny he thought there was a miniscule chance it would cause me problems down the road and he did not recommend radiation therapy or hormonal therapy with their associated risks and side effects for my particular situation. He actually told me I was not to lose sleep over this or worry about it and he never expected to see me again. I also met with a radiation oncologist who wavered a bit on his recommendation, (seems I was sort of in a 'gray' area on rad treatments mainly because of my age at that time - 46 - and one margin although clear was quite 'close' at 1.3 mm) but ultimately told me after we had a long discussion that I get a 'pass'. Therefore, I decided against doing anything more except for close monitoring with mammograms and MRI's as needed.I have had two additional biopsies since the initial diagnosis of that tiny area of DCIS. In summer of 2011 microcalc's were again found in that same left breast and I endured another excisional biopsy which indicated all benign conditions. In July 2012 a small grouping of microcalc's (less than ten) were again showing up in left breast on mamm and I had a stereotactic biopsy to remove the majority of them which also came back benign. They put a 'marker' in at the time of stereo biopsy and I have had follow up mamm's since then which thankfully continue to be 'stable' in that area. This past July I had my first 3D mammogram and still received report of 'stable' - I am at the point now, eight years since first lumpectomy/surgical excision, of being back to annual checks. My DCIS was a very, very tiny area, but I did not choose to do radiation or any further treatment.

  • LAstar
    LAstar Member Posts: 1,574
    edited October 2016

    How wide were your margins?

  • Tadykins
    Tadykins Member Posts: 12
    edited October 2016

    Thank you Momzr for your reply. I am just nervous about my dcis being grade 3. I am glad things worked out for you and I do think if it is possible not to have rads it must be better for us with the side and long term effects. maybe time will help settle my nerves. does it ever get easier? will it always be there lingering in our minds and sometimes making us feel vulnerable . Thank you once again for your reply and it has helped me.❤

  • Tadykins
    Tadykins Member Posts: 12
    edited October 2016

    Hi LAstar , I was told that my margins were clear and they were very happy with them, I don't recall them saying how wide they were. Thanks .

  • momzr
    momzr Member Posts: 111
    edited October 2016

    Tadykins - I think it might always be somewhat in the 'back of your mind' although as the years go on, not quite as much. I still get a bit nervous when it is time for that annual mammogram, but just always forewarn my family I might be a bit 'out of sorts' . . . I'm sure you will probably be on the six month mammogram routine for a little while which should help keep an eye on things. Good luck!

  • LAstar
    LAstar Member Posts: 1,574
    edited October 2016

    This is a recent study that compared recurrence rates for different margin widths for people who were and were not treated with radiation. The benefit of radiation is the least when clear margins are greater than 1cm. However, the effect of radiation was significant regardless of margin width. I haven't read this study closely, but it contains interesting information based on reasonable sample sizes.

    http://www.ascopost.com/issues/april-25-2016/in-du...


  • suzydthatisme
    suzydthatisme Member Posts: 28
    edited October 2016

    I was recently diagnosed with DCIS, grade 1, and I was referred to a radiation oncologist after my lumpectomy. She told me about the two largest studies on DCIS, what the risks there are with radiation treatment (although rare, possible heart damage and lung cancer down the road) and then left it up to me to decide. She said that for my situation the stats are as follows: 96% chance it won't recur with radiation, 90% it won't recur with no radiation. I opted for no radiation. She seemed pleased with my decision and said that they'd be on top of it if it came back. As I'm being followed at a major cancer centre, I trust their judgement and expertise. Like she said, everyone's tolerance for risk is different....some people want to throw the kitchen sink at it and others are willing to take a more laid back approach. I'm not overly concerned. My margins were good: 4 mm and 5mm and there was no comedo activity. She said that 1 cm. margins are optimal but it's difficult to get that without causing cosmetic problems with the breast. I reckon the odds are in our favour on this one and with a bit of luck we won't have to deal with this again in the future. Good luck to you!

  • Tadykins
    Tadykins Member Posts: 12
    edited October 2016

    momzr thank you for getting back to me. My next mammogram is shedualed for Feb next year. I live in Ireland and here your follow up mamo is on a 12 month basis not 6 like where you are. I have a bit of a wait yet and I do think this also adds to the reasons I am nervous about my treatment. ❤

    LAstar thank you for that link you sent me. I am not great at understanding these but what I have picked up from it rightly or wrongly is that after a lumectomy ,radiation gives benefits to all regardless of margins and other factors. ??❤

    suzydthatisme , thank you for taking the time to answer my query. I do understand where you are coming from. I have noticed that rads is recommended for grade 3 dcis by many of the sites I have Google. I am glad you are happy with your hospital care and that you are confident with your treatment, wish I felt the same way❤

  • LAstar
    LAstar Member Posts: 1,574
    edited October 2016

    Tadykins, that's how I interpreted the research also. I would want to know my margin width so I would have a better idea of my risk of recurrence. If you found out that your margin was >1cm, what would you do? Is it worth going through radiation treatment to reduce your recurrence risk from 16% to 10%? Those numbers are statistically different, but it might not be worth it to you. Notice also that nuclear grade is not addressed in this summary, and grade 3 is usually treated more seriously than grade 1. The classification of margins between 2mm and 10mm is fairly broad. How would those recurrence rates change if that classification was 2-5mm and 5+mm? They didn't have enough data to estimate recurrence this way, so there is not enough information to determine what a reasonable cutoff is. If you look at the recurrence rates after radiation for all three negative margin classes, the recurrence rates are very similar (12%, 13%, and 10%). Radiation is definitely effective! For me, I think I would rest easy with margins >1cm. You might want to get a second opinion to ease your mind. There has been a lot of press about the overtreatment of DCIS, but so many of those discussions don't mention nuclear grade which is very important. If your radiologist has a personal opinion about DCIS overtreatment that doesn't match your risk tolerance, maybe you should consult with a different radiologist.

  • LAstar
    LAstar Member Posts: 1,574
    edited October 2016

    I don't want to add to your concerns! When I was going through these kinds of decisions, I went to the data (I'm a statistician). I get a lot of comfort from letting the research inform my decisions, but it's always hard to remove the emotion from the process.

  • Dizzybee
    Dizzybee Member Posts: 142
    edited October 2016

    Tadykins, it may be a good idea to get a second opinion to put your mind at rest. It may be that the decision not to have radiotherapy is because the risk/ benefit analysis on such a tiny tumour means you are safer not having it. And it's worth remembering, if anything ever did recur, you can have radiotherapy next time. DCIS if it recurs is DCIS again 50% of the time. If mine recurs it will have to be a mastectomy. You still have an weapon in reserve.

    My mammogram interval is yearly for the first 5 years and every 18 months for the next 6, then it's back to 3 years. It does make me nervous.

    I would get an appointment to talk this over with your oncology team because it could make you feel happier that this was the right decision, or they may be able to talk about other options. Is it definitely too late to have rads? The chemo girls have rads way down the line after surgery.

  • Dizzybee
    Dizzybee Member Posts: 142
    edited October 2016

    LAStar, thanks for the link to the article. Now I'm thinking maybe I don't need rads after all, since I had a re excision with no disease found. The article is saying that with either clear re excision sample or big margins there's very little benefit to doing rads.

    But this is only one study so I guess I will take the advice I'm given and do rads, since I'm being quoted a 50% reduction in risk by doing rads and Tamoxifen.

    I'm glad this is only DCIS but it still is a scary diagnosis, and being grade 3 feels very risky.

  • LAstar
    LAstar Member Posts: 1,574
    edited October 2016

    Dizzybee, that's great that you got large clear margins with such a large area of DCIS. I had involved margins with both lumpectomies and had to have MX to deal with it. In my second lumpectomy, one of the margins that had been assessed as clear in the first lumpectomy was involved in the second lumpectomy. It seems that DCIS can have "skips" in the ducts so it's not necessarily continuous throughout. I think that this is one of the reason that radiation is so effective in lowering recurrence rates. Note that even in the clear margin category of the study, the radiation treatment was associated with a reduction of the recurrence risk from 1-in-6 to 1-in-10. That effect is statistically significant based on the p-value of the test of the hazard ratio. Certainly we all have to determine how that measures against our own risk threshold.

  • BarredOwl
    BarredOwl Member Posts: 2,433
    edited October 2016

    For information only, and subject to discussion and confirmation of understanding with one's treatment team, please see the following new guideline pertinent to margin sizes for those receiving breast-conserving surgery ("lumpectomy") and whole breast irradiation ("WBRT") for DCIS:

    SSO ASRO ASCO (2016): http://jco.ascopubs.org/content/early/2016/08/10/JCO.2016.68.3573.full

    (A pdf version is available at the above link, making the tables easier to read.)

    "There are limitations to this guideline. It applies to patients with DCIS and DCIS-M treated with WBRT. The findings should not be extrapolated to DCIS patients treated with APBI or those with invasive carcinoma for whom a separate guideline has been developed.(33) While studies including patients treated with and without WBRT were included in the meta-analysis, a meta-analysis of studies of treatment with excision alone was not conducted. Additionally, all of the studies included in the meta-analysis were retrospective. However, in the absence of any planned prospective randomized trials addressing the question of margin width and local recurrence, these studies represent the best available evidence for clinical decision making."

    There is a section entitled, "Treatment with Excision Alone" that includes a top-line discussion with citations to a various clinical studies of interest.

    I note that with breast conserving therapy ("BCT"), those with DCIS should look to the above BCT / DCIS guideline, while those with invasive disease should in general look to the separate BCT / invasive guidelines. However, there is overlap between the DCIS Margin Guideline and the Invasive Cancer Margin Guideline for DCIS with micro-invasion (DCIS-M or DCIS-MI), a point to discuss with one's Radiation Oncologist, if applicable.

    I linked to other guideline documents applicable to different situations here:

    https://community.breastcancer.org/forum/68/topics/847670?page=1#post_4796674

    BarredOwl

  • Dizzybee
    Dizzybee Member Posts: 142
    edited October 2016

    LAStar and Barred Owl

    Ever since I got diagnosed not very long ago, I've struggled with the statistics. As someone who was never any good at math, I don't feel confident that I understand when the figures are bandied around. So there is a conflict between wanting to be well-informed, and feeling I don't have the training or understanding to challenge the experts when it comes to decision making. But it seems like most of the decisions are around statistical risk reduction. Rads will reduce the risk of recurrence by this much, and Tamoxifen by this much more. So in the end I guess I will assume that the oncologist knows his/her stuff and follow their recommendations.

    But it is great to come here and find the links to the studies and women who are much better able than me to understand them. But if I've got this right, Barred Owl's meta study is mostly not in agreement with the first study, it is saying that once you get the optimum margin of 2 millimeters there's little evidence of any greater benefit from bigger margins. That's a bit of a shame since I think I have probably have very big margins now! The pathology report gives the biggest dimension as 95 millimeters for my 5 centimetre tumour. But that was after re excision as the first time round had margins of half a millimeter on two sides.

    LAStar, yes, I think my surgeon was also amazed the new sample came back clear, we'd agreed it would have to be mx if it wasn't. The original sample showed a multifocal solid tumour with comedo necrosis, but no microinvasion, but I was thinking maybe they'd find either microinvasion or full IDC.

    And I even have a good shape, due to some neat oncoplastic lift and reduction surgery, which is probably why I have such good margins, the surgeon said redoing it would be difficult after it had all been moved around.

  • LAstar
    LAstar Member Posts: 1,574
    edited October 2016

    The Van Zee paper cited in the meta-analysis that BarredOwl posted is the study that I posted before. The Van Zee research found a relationship between margin width and recurrence rates when radiation was NOT used, but no significant difference in recurrence rates when radiation therapy WAS used. I interpret this as indicating that margin width is very important when deciding if one is going to choose radiation therapy, but the research seems pretty solid that radiation is effective in decreasing the recurrence rate regardless of margin width. If that decrease in risk is worth going through the treatment is an individual's call.

  • BarredOwl
    BarredOwl Member Posts: 2,433
    edited October 2016

    Hi Tadykins:

    You didn't mention the estrogen receptor (ER) or progesterone receptor (PR) status of your DCIS. If your DCIS was hormone receptor-positive (ER+ and/or PR+), then you would have the additional option of endocrine therapy (i.e., a type of anti-hormonal treatment). Endocrine therapy can reduce the risk of second events (of DCIS or invasive breast cancer) in the same or opposite breast. If you had hormone receptor-positive disease and have not yet consulted with a "medical oncologist", you may wish to request a referral and appointment with a medical oncologist as soon as possible to discuss the potential benefits and risks of endocrine therapy in your particular case. Endocrine therapy could be tamoxifen (pre-menopausal or post-menopausal). If post-menopausal, you would have the additional option of an aromatase inhibitor. If you elect endocrine therapy, it would be preferable to initiate it as soon as feasible.

    BarredOwl

  • Dizzybee
    Dizzybee Member Posts: 142
    edited October 2016

    BarredOwl, I was told that Tamoxifen was the only treatment that was approved for DCIS, regardless of your hormone status, that there weren't enough studies to demonstrate effectiveness of AIs. I'm in the UK so maybe we have different treatment protocols.

    Anyway I'm hoping if I'm post menopause there won't be many side effects, can't have all that much estrogen anyway. Or doesn't it work like that?

  • Tadykins
    Tadykins Member Posts: 12
    edited October 2016

    Hi ,

    LAstar, thank you so much for your reply and I think I am in the same mind frame as you. I do find when I look up the links about treatments and data for Dcis etc I get lost in the terminologies and have to read over them a good few times to grasp what they imply. I would not be the smartest bulb in the box and I do find it difficult trying to understand it all. I never heard of Dcis until I was told I had it and everyone I have spoken to in my social circle never heard of it either. I was told by my surgeon before I met with the radioligist that rads have to start 5 weeks after lumpectomy so its too late now for rads for me. I do feel more informed now about Dcis and it is all thanks to the help of people like you X

    Dizzybee, thank you so much for your reply. I do understand what you are saying and like you said I still have a weapon in reserve should I ever need it in the future. I think it is because of it being a grade 3 that has me nervous but I think I will wait until my next mamo and subsequent appointment with my surgeon and see how things are then. I will be better prepared and informed for these upcoming appointments due to all the help and advise and information I have gotten due to this site and the wonderful women who are willing to share their time and knowledge with others. I thank you all. X

    BarredOwl , thank you so much for your reply, I did not mention the hormone receptor status of my Dcis because I don't know the answer.!! I don't recall being told so maybe there is'nt none??I am 55 years old and hopefully post menopausal but not sure as sometimes I get flushes but defo not as often as I did.X

  • LAstar
    LAstar Member Posts: 1,574
    edited October 2016

    Tadykins, since your radiation window has past, I think the best approach is to stay vigilant on self-exams and check-ups and then just live a great life! You got the elusive miracle margins. And don't put yourself down for not getting all the statistics! I have a PhD in statistics, but this stuff was too close for me to digest the first (or second or more) time. It's a very emotional time for in-depth scientific research!

  • BarredOwl
    BarredOwl Member Posts: 2,433
    edited October 2016

    Hi Tadykins:

    Please do not hesitate to call your surgeon and inquire about your ER and PR status, based on the biopsy or surgical pathology report. As best practice for patients, I would also recommend that you (and all patients) request copies of the pathology reports from all biopsies and surgeries for your review and records.

    The pathology reports (including any addenda and supplements) should include information about any ER and PR testing that was done on your tissue. The purpose of obtaining these reports is not to second-guess your decision about radiation (which was made on the advice of a professional with full knowledge of applicable clinical and pathologic factors of your case).

    The goal of these steps would be for you to learn additional details of your diagnosis, and to find out whether you may have another risk-reducing option available to you (i.e., endocrine therapy). If the DCIS was hormone receptor-positive (ER+ and/or PR+), then you may choose to consult a medical oncologist about the option of endocrine therapy and whether it is right for you or not. This would enable you to make an informed decision about it (regardless or whether you elect or decline it).

    I do not think the window for initiating endocrine therapy has closed, but the process of inquiring about ER and PR status and seeking consultation about endocrine therapy should be initiated at this time and not deferred, if of interest.

    BarredOwl

  • BarredOwl
    BarredOwl Member Posts: 2,433
    edited October 2016

    Hi Dizzybee:

    There may be differences in local practice. Tamoxifen is FDA-approved in the DCIS setting, and has been in use for DCIS for many years. Although not yet FDA-approved in the DCIS setting, aromatase inhibitors have recently been added to our local National Comprehensive Cancer Network (NCCN) guidelines for treatment of breast cancer (Version 2.2016) as an option for post-menopausal DCIS patients, based on recent results from the NSABP B-35 and IBIS-II trials. The NCCN guidelines include the comment "with some advantage for aromatase inhibitor therapy in patients <60 years old or with concerns for thromboembolism." Here are links to the studies:

    "Anastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, phase 3 clinical trial"

    Margolese (2016): http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)01168-X/fulltext

    "Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial"

    Forbes (2016): http://www.thelancet.com/pdfs/journals/lancet/PIIS0140-6736(15)01129-0.pdf

    I note that the latest version of the ESMO (European Society for Medical Oncology) guidelines was published in 2015, prior to the publication of the above two studies. NICE probably has a separate guideline. In any event, the selection of a particular drug by the medical oncologist takes into account a variety of factors.

    BarredOwl

  • Dizzybee
    Dizzybee Member Posts: 142
    edited October 2016

    BarredOwl, thanks for the information. I guess if I have problems with Tamoxifen and want to transfer to AIs it will be useful to bring to the discussion. As ever, it's a case of weighing up the side effects, do I want increased risk of heart disease, stroke and DVT or joint and muscle pain? At the moment I'm hoping for the best that Tamoxifen will suit me, but it's good to know there is something else out there if there is a problem.

    There is so much detailed information on these boards, thanks for bringing it to the table for the rest of us!

Categories